Quarterly Results • Search Archive

Ipca Laboratories Limited
Results, Financials & Updates

Follow Ipca Laboratories Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Ipca Laboratories Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: IPCALAB
Revenue from operations₹2,788.10 CrReported in the latest covered quarter
Profit after tax₹424.27 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Ipca Laboratories Limited is a fully integrated Indian pharmaceutical company with a strong international footprint, specializing in the manufacture and marketing of both Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). The company's commercial operations span domestic formulations, international branded and institutional formulations, export generics, and active pharmaceutical ingredients, supported by extensive manufacturing infrastructure.

← All quarterly results

Quarter history

Ipca Laboratories Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹2,788.10 Cr · PAT ₹424.27 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.